Skip to main content
Clinical Trials/CTRI/2020/07/026285
CTRI/2020/07/026285
Not yet recruiting
Phase 2

Preclinical and Clinical Evaluation of Therapeutic Management for Maantha Sanni (Autism Spectrum Disorder) in Children with Siddha System of Medicine Including Thuvaalai

ational institute of siddha0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: F840- Autistic disorder
Sponsor
ational institute of siddha
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Clinically diagnosed as Autism Spectrum Disorder(ASD)
  • \-Meets the diagnostic symptoms of
  • ï??Has poor eye contact
  • ï??Inappropriate emotional response
  • ï??Acquired speech or lost it
  • ï??Engages in stereotyped and repetitive behaviour
  • ï??Mild aggressive behaviour
  • ï??Lack of communication skills
  • ï??Some congenital anomalies

Exclusion Criteria

  • The conditions that co\-occur with autism
  • \-Attention deficit hyperactivity disorder(ADHD)
  • \-Seizure with hyperactivity
  • \-Cerebral palsy with hyperactivity
  • \-Severe aggressive behaviour
  • Any other serious illness

Outcomes

Primary Outcomes

Not specified

Similar Trials